S. Ohya, M. Matsui, and J. Kajikuri, “Ca 2+ -Activated K + Channel K Ca 3.1 as a Double-Edged Sword in the Treatment of Inflammatory Bowel Disease”, JGLD, vol. 29, no. 4, pp. 487–489, Dec. 2020.